Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli | 7 | 2022 | 995 | 1.070 |
Why?
|
| PPAR gamma | 7 | 2020 | 89 | 1.020 |
Why?
|
| beta-Lactamases | 3 | 2009 | 208 | 0.740 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2022 | 382 | 0.670 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 409 | 0.660 |
Why?
|
| Escherichia coli Proteins | 1 | 2022 | 316 | 0.630 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 2442 | 0.570 |
Why?
|
| Hypertension, Pulmonary | 4 | 2023 | 463 | 0.550 |
Why?
|
| Biphenyl Compounds | 2 | 2015 | 56 | 0.480 |
Why?
|
| Homeostasis | 2 | 2019 | 722 | 0.480 |
Why?
|
| Osteogenesis | 2 | 2015 | 163 | 0.450 |
Why?
|
| Osteoblasts | 1 | 2015 | 161 | 0.430 |
Why?
|
| Indoles | 1 | 2015 | 201 | 0.430 |
Why?
|
| Bacterial Proteins | 8 | 2014 | 930 | 0.420 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 482 | 0.420 |
Why?
|
| Biological Evolution | 1 | 2014 | 243 | 0.390 |
Why?
|
| Bone and Bones | 1 | 2015 | 301 | 0.390 |
Why?
|
| Mutant Proteins | 2 | 2009 | 117 | 0.380 |
Why?
|
| Pulmonary Artery | 5 | 2023 | 463 | 0.370 |
Why?
|
| Endogenous Retroviruses | 2 | 2022 | 19 | 0.370 |
Why?
|
| Mutation | 7 | 2022 | 6243 | 0.370 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 1423 | 0.370 |
Why?
|
| Suppression, Genetic | 2 | 2008 | 42 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2553 | 0.330 |
Why?
|
| Endothelial Cells | 4 | 2023 | 526 | 0.320 |
Why?
|
| Catalytic Domain | 1 | 2009 | 179 | 0.300 |
Why?
|
| Proline | 1 | 2008 | 77 | 0.290 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1964 | 0.270 |
Why?
|
| Serratia marcescens | 1 | 2007 | 11 | 0.270 |
Why?
|
| Leucine | 1 | 2008 | 260 | 0.270 |
Why?
|
| Arginine | 1 | 2009 | 343 | 0.260 |
Why?
|
| Imidazoles | 2 | 2020 | 219 | 0.260 |
Why?
|
| Piperazines | 2 | 2020 | 255 | 0.250 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2020 | 766 | 0.220 |
Why?
|
| Crystallography, X-Ray | 8 | 2017 | 387 | 0.220 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2022 | 827 | 0.210 |
Why?
|
| Serine Endopeptidases | 3 | 2014 | 188 | 0.210 |
Why?
|
| Mitochondrial Dynamics | 1 | 2024 | 55 | 0.200 |
Why?
|
| Protein Conformation | 6 | 2017 | 826 | 0.200 |
Why?
|
| RNA, Small Untranslated | 1 | 2022 | 21 | 0.190 |
Why?
|
| Models, Molecular | 8 | 2017 | 1120 | 0.190 |
Why?
|
| Colistin | 1 | 2022 | 32 | 0.190 |
Why?
|
| Ciprofloxacin | 1 | 2022 | 66 | 0.180 |
Why?
|
| DNA Repair | 2 | 2019 | 566 | 0.180 |
Why?
|
| Vascular Diseases | 1 | 2023 | 150 | 0.180 |
Why?
|
| Pyrophosphatases | 1 | 2021 | 22 | 0.180 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2020 | 20 | 0.170 |
Why?
|
| Selection, Genetic | 2 | 2014 | 164 | 0.170 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 241 | 0.160 |
Why?
|
| Periplasmic Proteins | 2 | 2010 | 6 | 0.160 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 210 | 0.150 |
Why?
|
| Proteins | 3 | 2014 | 1037 | 0.150 |
Why?
|
| Retinoid X Receptor alpha | 2 | 2017 | 17 | 0.150 |
Why?
|
| Monocytes | 1 | 2021 | 342 | 0.150 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2018 | 33 | 0.150 |
Why?
|
| Sequence Analysis, Protein | 3 | 2013 | 48 | 0.150 |
Why?
|
| Molecular Sequence Data | 8 | 2012 | 3771 | 0.150 |
Why?
|
| HEK293 Cells | 3 | 2019 | 799 | 0.150 |
Why?
|
| Viral Vaccines | 1 | 2021 | 343 | 0.150 |
Why?
|
| DNA | 2 | 2017 | 1479 | 0.150 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2018 | 19 | 0.140 |
Why?
|
| Regeneration | 1 | 2020 | 225 | 0.140 |
Why?
|
| Molecular Docking Simulation | 1 | 2018 | 142 | 0.140 |
Why?
|
| 3T3-L1 Cells | 2 | 2015 | 58 | 0.140 |
Why?
|
| Crystallography | 2 | 2015 | 39 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2019 | 2490 | 0.140 |
Why?
|
| Oncogene Protein tpr-met | 1 | 2017 | 1 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 297 | 0.130 |
Why?
|
| Kinetics | 2 | 2009 | 1130 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 628 | 0.130 |
Why?
|
| Deuterium Exchange Measurement | 2 | 2017 | 8 | 0.130 |
Why?
|
| Macrophages | 1 | 2021 | 692 | 0.130 |
Why?
|
| Plasmids | 2 | 2008 | 459 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2017 | 148 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 201 | 0.120 |
Why?
|
| Binding Sites | 5 | 2018 | 1256 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 375 | 0.120 |
Why?
|
| Gene Editing | 1 | 2018 | 212 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2015 | 1611 | 0.120 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 295 | 0.120 |
Why?
|
| Models, Genetic | 2 | 2018 | 771 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2010 | 651 | 0.110 |
Why?
|
| Adipogenesis | 1 | 2015 | 80 | 0.110 |
Why?
|
| Protein Binding | 5 | 2019 | 1733 | 0.110 |
Why?
|
| Mice | 8 | 2023 | 18504 | 0.110 |
Why?
|
| Ligands | 4 | 2018 | 495 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 92 | 0.110 |
Why?
|
| Amino Acid Sequence | 7 | 2012 | 2669 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 356 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 386 | 0.100 |
Why?
|
| Oxidative Stress | 3 | 2024 | 801 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2021 | 4720 | 0.100 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2023 | 20 | 0.100 |
Why?
|
| Feedback | 1 | 2014 | 166 | 0.100 |
Why?
|
| Animals | 10 | 2023 | 34842 | 0.100 |
Why?
|
| Evolution, Molecular | 3 | 2013 | 700 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2011 | 310 | 0.100 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 2 | 2023 | 15 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1284 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 2 | 2009 | 101 | 0.090 |
Why?
|
| Sequence Alignment | 5 | 2012 | 615 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2011 | 11 | 0.090 |
Why?
|
| Rec A Recombinases | 1 | 2011 | 26 | 0.090 |
Why?
|
| DNA, Bacterial | 2 | 2018 | 494 | 0.090 |
Why?
|
| Protein Structure, Secondary | 2 | 2009 | 246 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 462 | 0.090 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2010 | 16 | 0.090 |
Why?
|
| Thermotoga maritima | 1 | 2010 | 1 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1034 | 0.080 |
Why?
|
| Exodeoxyribonucleases | 1 | 2010 | 52 | 0.080 |
Why?
|
| Prokaryotic Cells | 1 | 2009 | 8 | 0.080 |
Why?
|
| Humans | 18 | 2024 | 132199 | 0.080 |
Why?
|
| Bacteroides | 1 | 2010 | 37 | 0.080 |
Why?
|
| Endodeoxyribonucleases | 1 | 2010 | 47 | 0.080 |
Why?
|
| DNA, Single-Stranded | 1 | 2010 | 69 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 286 | 0.080 |
Why?
|
| Apoptosis | 2 | 2015 | 1901 | 0.080 |
Why?
|
| Caulobacter crescentus | 1 | 2009 | 3 | 0.080 |
Why?
|
| Phosphotransferases | 1 | 2009 | 40 | 0.080 |
Why?
|
| Histidine | 1 | 2009 | 77 | 0.080 |
Why?
|
| Computational Biology | 1 | 2014 | 876 | 0.070 |
Why?
|
| Enzyme Stability | 1 | 2008 | 59 | 0.070 |
Why?
|
| Ampicillin | 1 | 2008 | 58 | 0.070 |
Why?
|
| Microbial Viability | 1 | 2008 | 42 | 0.070 |
Why?
|
| Hydrolysis | 1 | 2008 | 158 | 0.070 |
Why?
|
| DNA Damage | 2 | 2023 | 511 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2008 | 145 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2008 | 198 | 0.070 |
Why?
|
| Protein Sorting Signals | 1 | 2007 | 41 | 0.070 |
Why?
|
| Software | 1 | 2012 | 731 | 0.070 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2007 | 51 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 2961 | 0.070 |
Why?
|
| Phylogeny | 1 | 2009 | 763 | 0.070 |
Why?
|
| Carbapenems | 1 | 2007 | 43 | 0.070 |
Why?
|
| Genes, Bacterial | 1 | 2007 | 217 | 0.060 |
Why?
|
| DNA Primers | 1 | 2007 | 636 | 0.060 |
Why?
|
| Proteome | 2 | 2021 | 279 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2010 | 812 | 0.060 |
Why?
|
| Bacteria | 1 | 2009 | 522 | 0.060 |
Why?
|
| Inflammation | 2 | 2024 | 1520 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2010 | 764 | 0.050 |
Why?
|
| Vascular Remodeling | 1 | 2023 | 54 | 0.050 |
Why?
|
| Elafin | 1 | 2022 | 2 | 0.050 |
Why?
|
| Vinculin | 1 | 2022 | 7 | 0.050 |
Why?
|
| Leukocyte Elastase | 1 | 2022 | 19 | 0.050 |
Why?
|
| Base Sequence | 1 | 2007 | 2900 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 94 | 0.050 |
Why?
|
| RNA Polymerase III | 1 | 2022 | 41 | 0.050 |
Why?
|
| CD146 Antigen | 1 | 2021 | 6 | 0.050 |
Why?
|
| Snail Family Transcription Factors | 1 | 2021 | 25 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 2 | 2013 | 157 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 387 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2022 | 422 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 271 | 0.040 |
Why?
|
| Structural Homology, Protein | 2 | 2010 | 27 | 0.040 |
Why?
|
| Neutrophils | 1 | 2022 | 360 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 1980 | 0.040 |
Why?
|
| Farnesol | 1 | 1999 | 4 | 0.040 |
Why?
|
| Salicylates | 1 | 1999 | 54 | 0.040 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 1999 | 15 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2010 | 296 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 519 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2024 | 784 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2019 | 100 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 65 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 596 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 172 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 137 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 1045 | 0.030 |
Why?
|
| Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2017 | 2 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 120 | 0.030 |
Why?
|
| Leucine Zippers | 1 | 2017 | 18 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2019 | 246 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2018 | 213 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 168 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 823 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 151 | 0.030 |
Why?
|
| Protein Folding | 1 | 2017 | 223 | 0.030 |
Why?
|
| Protein Domains | 1 | 2017 | 260 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2017 | 617 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2511 | 0.030 |
Why?
|
| Algorithms | 2 | 2013 | 1723 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2015 | 46 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1556 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3046 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 3015 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2015 | 811 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 301 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 1445 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 689 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 102 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 868 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3868 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 1999 | 897 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2011 | 37 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2011 | 76 | 0.020 |
Why?
|
| Body Fluids | 1 | 2011 | 47 | 0.020 |
Why?
|
| COS Cells | 1 | 2011 | 268 | 0.020 |
Why?
|
| Homologous Recombination | 1 | 2011 | 100 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2012 | 168 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 81 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 143 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2011 | 94 | 0.020 |
Why?
|
| Static Electricity | 1 | 2010 | 47 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 2724 | 0.020 |
Why?
|
| Adipocytes | 1 | 2011 | 182 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2011 | 279 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2010 | 88 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1999 | 1829 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 2009 | 31 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 93 | 0.020 |
Why?
|
| Shewanella | 1 | 2008 | 10 | 0.020 |
Why?
|
| Weight Gain | 1 | 2011 | 381 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 666 | 0.020 |
Why?
|
| Dimerization | 1 | 2008 | 149 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 844 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1671 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 275 | 0.020 |
Why?
|
| Female | 3 | 2020 | 70754 | 0.010 |
Why?
|
| Male | 3 | 2020 | 64979 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 4758 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 4690 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 69 | 0.010 |
Why?
|
| Obesity | 1 | 2011 | 2398 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 272 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 436 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1999 | 174 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1999 | 604 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 744 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1999 | 7123 | 0.000 |
Why?
|
| Aged | 1 | 1999 | 21456 | 0.000 |
Why?
|